Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Nasopharyngeal Carcinoma 14 Triple Negative Breast Neoplasms 12 Carcinoma, Non-Small-Cell Lung 10 Esophageal Squamous Cell Carcinoma 9 Breast Neoplasms 8 Colorectal Neoplasms 7 Carcinoma, Renal Cell 7 Small Cell Lung Carcinoma 6 Neoplasms 6 Advanced Solid Tumor 6 Uterine Cervical Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 5 Head and Neck Neoplasms 5 Urinary Bladder Neoplasms 4 Recurrence 4 Carcinoma, Hepatocellular 4 Stomach Neoplasms 3 Solid Tumor 3 Neoplasm Metastasis 3 Liver Neoplasms 3 Carcinoma, Transitional Cell 3 Turcot syndrome 2 Sarcoma 2 Oropharyngeal Neoplasms 2 Nasopharyngeal Neoplasms 2 NSCLC 2 Muscle Invasive Bladder Cancer (MIBC) 2 Carcinoma, Squamous Cell 2 Biliary Tract Neoplasms 2 Advanced Solid Tumors 2

Interventions

Capecitabine 6 Oxaliplatin 5 camrelizumab 2 Radiation 2 Irinotecan 2 toripalimab 1 tislelizumab 1 spartalizumab 1 sintilimab 1 Radiotherapy, Intensity-Modulated 1 Leucovorin 1 Immune Checkpoint Inhibitors 1 Folfox protocol 1 Fluorouracil 1 Celecoxib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Locally Advanced Rectal Cancer × toripalimab × 1 year × Clear all

NCT06281405 2026-04-03

TORCH-iTNT

Fudan University

Phase 2 Recruiting

Gastrointestinal

Locally Advanced Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡